Various provinces in South Africa suffer from AVR shortage problem, accepts health dpt

South Africa’s health department recently revealed that it was aware that there is a shortage of antiretroviral drugs across various provinces in the country.

"The National department of Health has noted reports of shortage of a second line antiretroviral drugs (Lamividine) in some parts of the country," department's spokesperson Foster Mohale told Xinhua.

Gauteng, Free State, Mpumalanga and Limpopo are among affected provinces by the crisis. Foster Mohale blamed the problem on the lack of an ingredient used to manufacture antiretroviral drugs (ARV) globally.

"This shortage is as a result of the inability of a supplier to meet its contractual obligations due to a global shortage of the active pharmaceutical ingredient needed to manufacture the ARV. Provincial Departments of Health have been informed of the regimen that clinicians can switch patients to," Mohale said.

South Africa has about 4 million HIV positive people on ARVs and only 240,000 can afford to buy it from the private sector. Poor people get it from the government for free. This shortage only affected the poor who rely on the government for free treatment.

On the other hand, Anele Yawa, Secretary General of a health organization called Treatment Action Campaign, told Xinhua that HIV positive patients on these ARVs were being turned away from affected health institutions.

"There are drugs that are not available and also TB medicine. We spoke to the department which said there's a global crisis. In the Free State we visited six clinics which are turning people away," he said. Yawa said that thousands of patients have been affected since March and some health centers in Kwazulu Natal were without HIV test kits.

Also Read: Sichuan-based hospital unveils telemedicine service for São Tomé and Príncipe patients